Skip to main content

Ikarian Capital, LLC

Source: SEC Form 13F · as of Mar 2026

Ikarian Capital, LLC holds 74 biotech & pharma companies tracked by BioSniper, totaling $523.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

74

Total value held

$523.6M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Terns Pharmaceuticals, Inc. (TERN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
TERNTerns Pharmaceuticals, Inc.1,456,378$76.8M
KODKodiak Sciences Inc.1,265,795$48.3M
ALMSALUMIS INC.1,213,548$26.7M
PCVXVaxcyte, Inc.428,682$24.9M
HROWHARROW, INC.543,047$19.1M
RLMDRELMADA THERAPEUTICS, INC.2,688,359$18.7M
CYTKCYTOKINETICS INC283,572$18.7M
TENXTENAX THERAPEUTICS, INC.1,017,600$16.3M
CAPRCAPRICOR THERAPEUTICS, INC.528,015$16.1M
RVMDREVOLUTION MEDICINES, INC.163,142$15.9M
CLDXCelldex Therapeutics, Inc.461,247$14.6M
PHVSPharvaris N.V.486,856$13.8M
BBIOBridgeBio Pharma, Inc.160,120$11.9M
ORKAOruka Therapeutics, Inc.242,021$11.9M
SLNOSOLENO THERAPEUTICS INC344,123$11.5M
MAZEMaze Therapeutics, Inc.378,999$11.3M
ANIPANI PHARMACEUTICALS INC147,085$11.3M
IONSIONIS PHARMACEUTICALS INC127,038$9.5M
OLMAOlema Pharmaceuticals, Inc.598,281$8.9M
DMRADamora Therapeutics, Inc.335,710$8.7M
PVLAPALVELLA THERAPEUTICS, INC.64,626$8.1M
IVAInventiva S.A.1,429,101$7.8M
JBIOJade Biosciences, Inc.512,349$7.2M
OCGNOcugen, Inc.3,962,972$7.2M
ZURAZura Bio Ltd1,193,492$7.1M
OVIDOvid Therapeutics Inc.2,894,704$6.4M
ABVXAbivax SA57,635$6.2M
ACOGAlpha Cognition Inc.1,056,259$5.8M
PTHSPelthos Therapeutics Inc.256,598$5.4M
SRZNSurrozen Inc.173,107$5.0M
TECXTectonic Therapeutic, Inc.157,537$4.9M
ALECAlector, Inc.2,082,606$4.5M
LPCNLipocine Inc.508,556$4.1M
ARVNARVINAS, INC.358,257$3.8M
CMPSCOMPASS Pathways plc675,000$3.7M
BHVNBiohaven Ltd.412,481$3.5M
IVVDInvivyd, Inc.2,656,570$3.5M
ANNXAnnexon, Inc.580,244$3.2M
FBRXForte Biosciences, Inc.118,972$3.1M
BBOTBridgeBio Oncology Therapeutics, Inc.270,231$2.4M
PRQRProQR Therapeutics N.V.1,492,229$2.4M
NUVLNuvalent, Inc.23,594$2.4M
JAZZJazz Pharmaceuticals plc12,460$2.4M
KLRSKalaris Therapeutics, Inc.360,000$2.1M
SLDBSolid Biosciences Inc.264,409$1.9M
SLNSilence Therapeutics Plc865,784$1.7M
QUREuniQure N.V.91,060$1.5M
QNRXQuoin Pharmaceuticals, Ltd.211,538$1.4M
DFTXDefinium Therapeutics Inc.58,803$1.1M
LYELLyell Immunopharma, Inc.41,081$824K
KZRKezar Life Sciences, Inc.102,211$758K
IMUXIMMUNIC, INC.674,662$749K
CNTACentessa Pharmaceuticals plc18,113$719K
KALVKalVista Pharmaceuticals, Inc.35,119$707K
PMNProMIS Neurosciences Inc.55,000$699K
INSMINSMED Inc4,214$689K
ACADACADIA PHARMACEUTICALS INC28,099$625K
IMTXImmatics N.V.48,569$478K
VKTXViking Therapeutics, Inc.9,717$316K
SGMOQSANGAMO THERAPEUTICS, INC1,218,671$301K
VTGNVistagen Therapeutics, Inc.519,077$297K
VERUVERU INC.133,517$295K
EVAXEvaxion A/S74,698$278K
LXRXLEXICON PHARMACEUTICALS, INC.164,674$257K
VYGRVoyager Therapeutics, Inc.53,063$205K
NEUPNeuphoria Therapeutics Inc.47,443$193K
RNACCartesian Therapeutics, Inc.20,807$128K
CMPXCompass Therapeutics, Inc.18,000$95K
IOBTQIO Biotech, Inc.1,386,565$81K
CMMBChemomab Therapeutics Ltd.51,793$81K
PHGEBiomX Inc.19,473$73K
RZLTRezolute, Inc.16,479$50K
TOVXTheriva Biologics, Inc.112,076$22K
JSPRJasper Therapeutics Inc.24,093$21K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.